Multiple Assemblies exist for SMTL entry 6nr0
SIRT2(56-356) with covalent intermediate between mechanism-based inhibitor Glucose-TM-1beta and 1'-SH ADP-ribose; X-RAY DIFFRACTION 2.45 Å

SMTL ID 6nr0.1 Ligands ZINC ION; N~2~-[3-(2-hydroxyethoxy)propanoyl]-N-phenyl-N~6~-tetradecanethioyl-L-lysinamide; [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(3~{S},4~{R},5~{R})-3,4-bis(oxidanyl)-5-sulfanyl-oxolan-2-yl]methyl hydrogen phosphate; SODIUM ION; SULFATE ION; GLYCEROL Polypeptides NAD-dependent protein deacetylase sirtuin-2 Oligo-state homo-dimer

SMTL ID 6nr0.2 Ligands ZINC ION; N~2~-[3-(2-hydroxyethoxy)propanoyl]-N-phenyl-N~6~-tetradecanethioyl-L-lysinamide; [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(3~{S},4~{R},5~{R})-3,4-bis(oxidanyl)-5-sulfanyl-oxolan-2-yl]methyl hydrogen phosphate; SODIUM ION; SULFATE ION; GLYCEROL Polypeptides NAD-dependent protein deacetylase sirtuin-2 Oligo-state monomer